← Leaderboards
Kris C. Wood
Duke University
$5,294,947
Attributed
$5,294,947
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $777.2K · FY2008–25$1M$750K$500K$250K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,294,947 · 5
By mechanism
R01$4,786,487 · 3
R21$359,426 · 1
F32$149,034 · 1
Top collaborators
No co-investigators on record.
Most similar at Duke University
Same institution · by research overlap
- Edward A Miao$16,675,058
- Jennifer Ann Freedman$1,998,370
- Chuan-Yuan Li$14,248,346
- Derek Jantz$618,782
- Derek Wilson Cain$4,874,738
Others in their field
Top investigators on “Signal Transduction”
- Peter B. Gilbert · Fred Hutchinson Cancer Center$148,539,615
- David Heimbrook · Leidos Biomedical Research, Inc.$82,049,940
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$70,290,471
- Garret A Fitzgerald · University Of Pennsylvania$66,142,222
- Michael Barry Kastan · Duke University$64,512,357
- Randall J Bateman · Washington University$62,939,456
Research focus
Signal TransductionCellsTargeted TreatmentTumorAnimal ModelMolecularFoundationsAreaCell SurvivalCell DeathCredentialingScreeningNeoplastic CellGenomicsImproved OutcomeInhibitor TherapyGeneticGenesGenetically Engineered MouseInterestDependenceCombined Modality TherapyChronicExhibits
Grant awards (19)
Mechanism-based targeting of unique survival signaling in residual tumors$352,309
R01 · FY2025 · CA · contact PI
Lineage-specific signaling and targeting of PI3K gamma in myeloid malignancies$320,349
R01 · FY2025 · CA · contact PI
Lineage-specific signaling and targeting of PI3K gamma in myeloid malignancies$88,000
R01 · FY2025 · CA · contact PI
Lineage-specific signaling and targeting of PI3K gamma in myeloid malignancies$387,128
R01 · FY2024 · CA · contact PI
Mechanism-based targeting of unique survival signaling in residual tumors$335,400
R01 · FY2024 · CA · contact PI
Lineage-specific signaling and targeting of PI3K gamma in myeloid malignancies$402,262
R01 · FY2023 · CA · contact PI
Mechanism-based targeting of unique survival signaling in residual tumors$346,690
R01 · FY2023 · CA · contact PI
Lineage-specific signaling and targeting of PI3K gamma in myeloid malignancies$422,717
R01 · FY2022 · CA · contact PI
Mechanism-based targeting of unique survival signaling in residual tumors$354,451
R01 · FY2022 · CA · contact PI
Selectively targeting apoptosis in PIK3CA mutant colorectal cancers$357,092
R01 · FY2020 · CA · contact PI
Selectively targeting apoptosis in PIK3CA mutant colorectal cancers$346,622
R01 · FY2019 · CA · contact PI
Single cell functional dissection of tumor microenviornment-driven drug resistance$194,463
R21 · FY2019 · CA · contact PI
Selectively targeting apoptosis in PIK3CA mutant colorectal cancers$357,587
R01 · FY2018 · CA · contact PI
Single cell functional dissection of tumor microenviornment-driven drug resistance$164,963
R21 · FY2018 · CA · contact PI
Selectively targeting apoptosis in PIK3CA mutant colorectal cancers$357,824
R01 · FY2017 · CA · contact PI
Selectively targeting apoptosis in PIK3CA mutant colorectal cancers$358,056
R01 · FY2016 · CA · contact PI
A platform for genome-wide discovery of synthetic lethal interactions in cancer$52,154
F32 · FY2010 · CA · contact PI
A platform for genome-wide discovery of synthetic lethal interactions in cancer$50,054
F32 · FY2009 · CA · contact PI
A platform for genome-wide discovery of synthetic lethal interactions in cancer$46,826
F32 · FY2008 · CA · contact PI